AGILE THERAPEUTICS INC Annual Income Tax Expense (Benefit) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Agile Therapeutics Inc annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2014 to 2022.
  • Agile Therapeutics Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was -$4.68M.
  • Agile Therapeutics Inc annual Income Tax Expense (Benefit) for 2022 was -$4.68M.
  • Agile Therapeutics Inc annual Income Tax Expense (Benefit) for 2018 was -$477K.
  • Agile Therapeutics Inc annual Income Tax Expense (Benefit) for 2016 was -$3.08M, a 48.5% increase from 2015.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$4.68M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2018 -$477K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2016 -$3.08M +$2.9M +48.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$5.97M -$2.32M -63.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 -$3.65M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.